Literature DB >> 21462168

Infection of mice with Francisella as an immunological model.

J Wayne Conlan1, Wangxue Chen, Catharine M Bosio, Siobhán C Cowley, Karen L Elkins.   

Abstract

This unit describes the utility of various mouse models of infection for studying pathogenesis and adaptive immune responses to the facultative intracellular bacteria pathogen Francisella tularensis. By judicious use of different combinations of mouse and bacterial strains, as well as different routes of infection, murine tularemia models may be used to explore a complete picture of F. tularensis infection and immunity. Moreover, studies using Francisella, particularly the Live Vaccine Strain (LVS), serve as a convenient and tractable model system that appears to be representative of mammalian host responses to intracellular pathogens in general.
© 2011 by John Wiley & Sons, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21462168      PMCID: PMC3405980          DOI: 10.1002/0471142735.im1914s93

Source DB:  PubMed          Journal:  Curr Protoc Immunol        ISSN: 1934-3671


  22 in total

1.  Susceptibility to secondary Francisella tularensis live vaccine strain infection in B-cell-deficient mice is associated with neutrophilia but not with defects in specific T-cell-mediated immunity.

Authors:  C M Bosio; K L Elkins
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

2.  Oral tularemia vaccine in man.

Authors:  R B Hornick; A T Dawkins; H T Eigelsbach; J J Tulis
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1966

Review 3.  Tularemia as a biological weapon: medical and public health management.

Authors:  D T Dennis; T V Inglesby; D A Henderson; J G Bartlett; M S Ascher; E Eitzen; A D Fine; A M Friedlander; J Hauer; M Layton; S R Lillibridge; J E McDade; M T Osterholm; T O'Toole; G Parker; T M Perl; P K Russell; K Tonat
Journal:  JAMA       Date:  2001-06-06       Impact factor: 56.272

4.  Transfer of immunity against lethal murine Francisella infection by specific antibody depends on host gamma interferon and T cells.

Authors:  T R Rhinehart-Jones; A H Fortier; K L Elkins
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

5.  Experimental tularemia in mice challenged by aerosol or intradermally with virulent strains of Francisella tularensis: bacteriologic and histopathologic studies.

Authors:  J Wayne Conlan; Wangxue Chen; Hua Shen; Ann Webb; Rhonda KuoLee
Journal:  Microb Pathog       Date:  2003-05       Impact factor: 3.738

6.  Susceptibility of various mouse strains to systemically- or aerosol-initiated tularemia by virulent type A Francisella tularensis before and after immunization with the attenuated live vaccine strain of the pathogen.

Authors:  Hua Shen; Wangxue Chen; J Wayne Conlan
Journal:  Vaccine       Date:  2004-06-02       Impact factor: 3.641

7.  COMPARATIVE STUDIES OF FRANCISELLA TULARENSIS AND FRANCISELLA NOVICIDA.

Authors:  C R OWEN; E O BUKER; W L JELLISON; D B LACKMAN; J F BELL
Journal:  J Bacteriol       Date:  1964-03       Impact factor: 3.490

8.  Antimicrobial susceptibility testing of Francisella tularensis with a modified Mueller-Hinton broth.

Authors:  C N Baker; D G Hollis; C Thornsberry
Journal:  J Clin Microbiol       Date:  1985-08       Impact factor: 5.948

9.  Influence of genetic background on host resistance to experimental murine tularemia.

Authors:  L S Anthony; E Skamene; P A Kongshavn
Journal:  Infect Immun       Date:  1988-08       Impact factor: 3.441

10.  Multiple T cell subsets control Francisella tularensis LVS intracellular growth without stimulation through macrophage interferon gamma receptors.

Authors:  Siobhán C Cowley; Karen L Elkins
Journal:  J Exp Med       Date:  2003-07-28       Impact factor: 14.307

View more
  21 in total

1.  Increased Resistance to Intradermal Francisella tularensis LVS Infection by Inactivation of the Sts Phosphatases.

Authors:  Kaustubh Parashar; Erik Kopping; David Frank; Vinaya Sampath; David G Thanassi; Nick Carpino
Journal:  Infect Immun       Date:  2017-08-18       Impact factor: 3.441

2.  Differential role for interleukin-6 during Francisella tularensis infection with virulent and vaccine strains.

Authors:  Thomas R Laws; Graeme Clark; Riccardo V D'Elia
Journal:  Infect Immun       Date:  2013-05-28       Impact factor: 3.441

3.  Monophosphoryl Lipid A Enhances Efficacy of a Francisella tularensis LVS-Catanionic Nanoparticle Subunit Vaccine against F. tularensis Schu S4 Challenge by Augmenting both Humoral and Cellular Immunity.

Authors:  Katharina Richard; Barbara J Mann; Aiping Qin; Eileen M Barry; Robert K Ernst; Stefanie N Vogel
Journal:  Clin Vaccine Immunol       Date:  2017-03-06

4.  Novel catanionic surfactant vesicle vaccines protect against Francisella tularensis LVS and confer significant partial protection against F. tularensis Schu S4 strain.

Authors:  Katharina Richard; Barbara J Mann; Lenea Stocker; Eileen M Barry; Aiping Qin; Leah E Cole; Matthew T Hurley; Robert K Ernst; Suzanne M Michalek; Daniel C Stein; Philip Deshong; Stefanie N Vogel
Journal:  Clin Vaccine Immunol       Date:  2013-12-18

5.  Contaminated water delivery as a simple and effective method of experimental Salmonella infection.

Authors:  Hope O'Donnell; Oanh H Pham; Joseph M Benoun; Marietta M Ravesloot-Chávez; Stephen J McSorley
Journal:  Future Microbiol       Date:  2015-10-06       Impact factor: 3.165

6.  MyD88-dependent signaling prolongs survival and reduces bacterial burden during pulmonary infection with virulent Francisella tularensis.

Authors:  Brian C Russo; Matthew J Brown; Gerard J Nau
Journal:  Am J Pathol       Date:  2013-08-03       Impact factor: 4.307

7.  Development of functional and molecular correlates of vaccine-induced protection for a model intracellular pathogen, F. tularensis LVS.

Authors:  Roberto De Pascalis; Alicia Y Chou; Catharine M Bosio; Chiung-Yu Huang; Dean A Follmann; Karen L Elkins
Journal:  PLoS Pathog       Date:  2012-01-19       Impact factor: 6.823

8.  Francisella tularensis induces Th1 like MAIT cells conferring protection against systemic and local infection.

Authors:  Zhe Zhao; Huimeng Wang; Mai Shi; Alexandra J Corbett; Zhenjun Chen; Tianyuan Zhu; Troi Pediongco; Xin Yi Lim; Bronwyn S Meehan; Adam G Nelson; David P Fairlie; Jeffrey Y W Mak; Sidonia B G Eckle; Marcela de Lima Moreira; Carolin Tumpach; Michael Bramhall; Cameron G Williams; Hyun Jae Lee; Ashraful Haque; Maximilien Evrard; Jamie Rossjohn; James McCluskey
Journal:  Nat Commun       Date:  2021-07-16       Impact factor: 14.919

9.  A mucosal subunit vaccine protects against lethal respiratory infection with Francisella tularensis LVS.

Authors:  Amit R Ashtekar; Jannet Katz; Qingan Xu; Suzanne M Michalek
Journal:  PLoS One       Date:  2012-11-28       Impact factor: 3.240

10.  Tick extracellular vesicles enable arthropod feeding and promote distinct outcomes of bacterial infection.

Authors:  Adela S Oliva Chávez; Xiaowei Wang; Liron Marnin; Nathan K Archer; Holly L Hammond; Erin E McClure Carroll; Dana K Shaw; Brenden G Tully; Amanda D Buskirk; Shelby L Ford; L Rainer Butler; Preeti Shahi; Kateryna Morozova; Cristina C Clement; Lauren Lawres; Anya J O' Neal; Choukri Ben Mamoun; Kathleen L Mason; Brandi E Hobbs; Glen A Scoles; Eileen M Barry; Daniel E Sonenshine; Utpal Pal; Jesus G Valenzuela; Marcelo B Sztein; Marcela F Pasetti; Michael L Levin; Michail Kotsyfakis; Steven M Jay; Jason F Huntley; Lloyd S Miller; Laura Santambrogio; Joao H F Pedra
Journal:  Nat Commun       Date:  2021-06-17       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.